• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

US Patients Show Cautious Optimism Toward Generative AI in Healthcare

by Fred Pennic 08/13/2024 Leave a Comment

US Patients Show Cautious Optimism Toward Generative AI in Healthcare,

What You Should Know:  - New research from Bain & Company has revealed an intriguing trend in the healthcare industry: U.S. patients are more comfortable with generative artificial intelligence (AI) analyzing their radiology scans and making diagnoses than with AI answering the phone at their doctor's office. This finding underscores a broader trend where healthcare consumers show a preference for generative AI supporting their doctors rather than interacting directly with the
Read More

Vivid Health Expands GenAI Platform to Support Home Health Market

by Syed Hamza Sohail 08/13/2024 Leave a Comment

Vivid Health Expands GenAI Platform to Support Home Health Market

What You Should Know: - Vivid Health, an AI-powered care management company, today announced it’s expanding its generative AI platform to support the home health market. - The move will help home health agencies potentially double the number of patients they accept per day while also significantly reducing administrative burdens. Vivid Health: Revolutionizing Healthcare with Provider Led AI™ Vivid Health is a pioneering care management company harnessing the power of Provider Led AI™
Read More

PathAI Introduces AI-Based Measurement for MASH Scoring

by Fred Pennic 08/13/2024 Leave a Comment

PathAI Introduces AI-Based Measurement for MASH Scoring

What You Should Know:  - PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).  - The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score. AIM-MASH Integration with AISight By integrating AIM-MASH with AISight, PathAI
Read More

Citeline Launches AI-Powered Tools for Clinical Trials

by Jasmine Pennic 08/13/2024 Leave a Comment

Citeline Launches AI-Powered Tools for Clinical Trials

What You Should Know:  - Citeline, a provider of intelligence solutions for the life sciences industry, today announced the launch of Protocol SmartDesign and Investigator SmartSelect, two new AI-powered tools designed to streamline and optimize clinical trial development.  - These innovative solutions are part of the Citeline SmartSolutions suite, which leverages the company's extensive data assets to deliver actionable insights for life sciences organizations. How Protocol
Read More

AI-Driven Medication Advisor Launched by MedAdvisor and BEN

by Jasmine Pennic 08/13/2024 Leave a Comment

AI-Driven Medication Advisor Launched by MedAdvisor and BEN

What You Should Know:  - MedAdvisor Solutions and Brand Engagement Network (BEN) today announced the launch of their AI-driven medication advisor.  - This innovative solution is designed to enhance patient engagement, reduce pharmacist workload, and improve medication adherence. AI-driven Medication Advisor The medication advisor will be showcased at the upcoming National Association of Chain Drug Stores (NACDS) Total Store Expo, where attendees can interact with a
Read More

Absci and MSK Collaborate on Generative AI Drug Discovery

by Fred Pennic 08/12/2024 Leave a Comment

Absci and MSK Collaborate on Generative AI Drug Discovery

What You Should Know:  - Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics.  - By combining Absci’s AI platform with MSK’s renowned cancer research expertise, the partnership aims to accelerate the discovery and development of new treatments for this devastating disease. Absci's Integrated Drug Creation Platform Absci's Integrated
Read More

Create Health Ventures Launches $21M Fund to Invest in Digital Health Startups

by Fred Pennic 08/12/2024 Leave a Comment

Create Health Ventures Launches $21M Fund to Invest in Digital Health Startups

What You Should Know:  - Create Health Ventures, a venture capital firm dedicated to early-stage digital health startups, announced the closing of its $21M inaugural fund.  - The VC firm will invest in B2B solutions that address critical challenges within the healthcare industry, including improving patient engagement, enhancing care delivery, and optimizing clinical trials. Founding Team Founded by healthcare industry veterans Cartmell and Amit Aysola, Create Health Ventures brings
Read More

Sheba Medical Center Develops AI Algorithm to Predict Pulmonary Embolism

by Jasmine Pennic 08/12/2024 Leave a Comment

Sheba Medical Center Develops AI Algorithm to Predict Pulmonary Embolism

What You Should Know:  - Sheba Medical Center, a globally recognized healthcare leader, announced the publication of a groundbreaking study demonstrating the effectiveness of an AI algorithm in predicting pulmonary embolism (PE) risk upon hospital admission.  - The research, published in the Journal of Medical Internet Research, involved analyzing medical records of over 46,000 patients and identifying a machine learning model capable of accurately predicting PE
Read More

Patients Demand Improved Healthcare Support, Hyro Survey Finds

by Fred Pennic 08/09/2024 Leave a Comment

Patients Demand Improved Healthcare Support, Hyro Survey Finds

What You Should Know:  - A new survey conducted by Hyro, a healthcare AI-powered communications company, has revealed significant gaps in patient support within the US healthcare system.  - The survey of over 1,500 patients highlights the frustration and challenges patients face when interacting with healthcare providers. Patients Reveals Alarming Consequences of Healthcare Support Friction Hyro's "Voice of the Patient" report emphasizes the urgent need for healthcare
Read More

Luminopia’s Amblyopia Treatment Gains Coverage from Highmark

by Jasmine Pennic 08/09/2024 Leave a Comment

Luminopia's Amblyopia Treatment Gains Coverage from Highmark

What You Should Know:  - Luminopia, a digital health company focused on treating neuro-visual disorders, announced today that Highmark has approved coverage for its FDA-cleared therapy for children with amblyopia.  - This decision marks a significant milestone for Luminopia, as it expands access to its innovative treatment for a condition that affects millions of children. What is Amblyopia? Amblyopia, commonly known as lazy eye, is a leading cause of vision loss in
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 104
  • Go to page 105
  • Go to page 106
  • Go to page 107
  • Go to page 108
  • Interim pages omitted …
  • Go to page 730
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |